vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and PEAPACK GLADSTONE FINANCIAL CORP (PGC). Click either name above to swap in a different company.

PEAPACK GLADSTONE FINANCIAL CORP is the larger business by last-quarter revenue ($78.2M vs $75.5M, roughly 1.0× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 26.5%). PEAPACK GLADSTONE FINANCIAL CORP produced more free cash flow last quarter ($28.8M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 21.4%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Peapack Gladstone Financial Corp is a U.S.-based regional financial holding company that provides commercial and consumer banking, wealth management, private banking, lending solutions, and trust services, primarily serving individual and small-to-medium business clients across New Jersey and the surrounding U.S. Northeast region.

PBYI vs PGC — Head-to-Head

Bigger by revenue
PGC
PGC
1.0× larger
PGC
$78.2M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+1.3% gap
PBYI
27.7%
26.5%
PGC
More free cash flow
PGC
PGC
$14.4M more FCF
PGC
$28.8M
$14.4M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
21.4%
PGC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBYI
PBYI
PGC
PGC
Revenue
$75.5M
$78.2M
Net Profit
$12.2M
Gross Margin
69.3%
Operating Margin
22.7%
21.7%
Net Margin
15.5%
Revenue YoY
27.7%
26.5%
Net Profit YoY
31.6%
EPS (diluted)
$0.26
$0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
PGC
PGC
Q4 25
$75.5M
$78.2M
Q3 25
$54.5M
$70.7M
Q2 25
$52.4M
$69.7M
Q1 25
$46.0M
$64.4M
Q4 24
$59.1M
$61.8M
Q3 24
$80.5M
$56.6M
Q2 24
$47.1M
$56.6M
Q1 24
$43.8M
$53.1M
Net Profit
PBYI
PBYI
PGC
PGC
Q4 25
$12.2M
Q3 25
$8.8M
$9.6M
Q2 25
$5.9M
$7.9M
Q1 25
$3.0M
$7.6M
Q4 24
$9.2M
Q3 24
$20.3M
$7.6M
Q2 24
$-4.5M
$7.5M
Q1 24
$-4.8M
$8.6M
Gross Margin
PBYI
PBYI
PGC
PGC
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
PBYI
PBYI
PGC
PGC
Q4 25
22.7%
21.7%
Q3 25
17.6%
19.2%
Q2 25
12.7%
16.1%
Q1 25
8.7%
16.2%
Q4 24
22.6%
19.8%
Q3 24
27.4%
19.0%
Q2 24
-4.6%
16.9%
Q1 24
-5.3%
23.4%
Net Margin
PBYI
PBYI
PGC
PGC
Q4 25
15.5%
Q3 25
16.2%
13.6%
Q2 25
11.2%
11.4%
Q1 25
6.5%
11.8%
Q4 24
14.9%
Q3 24
25.2%
13.4%
Q2 24
-9.6%
13.3%
Q1 24
-11.0%
16.3%
EPS (diluted)
PBYI
PBYI
PGC
PGC
Q4 25
$0.26
$0.68
Q3 25
$0.17
$0.54
Q2 25
$0.12
$0.45
Q1 25
$0.06
$0.43
Q4 24
$0.40
$0.52
Q3 24
$0.41
$0.43
Q2 24
$-0.09
$0.42
Q1 24
$-0.10
$0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
PGC
PGC
Cash + ST InvestmentsLiquidity on hand
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$130.3M
$658.2M
Total Assets
$216.3M
$7.5B
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
PGC
PGC
Q4 25
$97.5M
Q3 25
$94.4M
Q2 25
$96.0M
Q1 25
$93.2M
Q4 24
$101.0M
Q3 24
$96.7M
Q2 24
$96.8M
Q1 24
$107.2M
Total Debt
PBYI
PBYI
PGC
PGC
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
PBYI
PBYI
PGC
PGC
Q4 25
$130.3M
$658.2M
Q3 25
$115.3M
$642.5M
Q2 25
$104.7M
$629.8M
Q1 25
$97.1M
$621.9M
Q4 24
$92.1M
$605.8M
Q3 24
$71.1M
$607.6M
Q2 24
$48.5M
$588.3M
Q1 24
$51.0M
$582.4M
Total Assets
PBYI
PBYI
PGC
PGC
Q4 25
$216.3M
$7.5B
Q3 25
$202.9M
$7.4B
Q2 25
$194.9M
$7.2B
Q1 25
$196.2M
$7.1B
Q4 24
$213.3M
$7.0B
Q3 24
$220.7M
$6.8B
Q2 24
$205.0M
$6.5B
Q1 24
$214.1M
$6.4B
Debt / Equity
PBYI
PBYI
PGC
PGC
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
PGC
PGC
Operating Cash FlowLast quarter
$14.4M
$43.1M
Free Cash FlowOCF − Capex
$14.4M
$28.8M
FCF MarginFCF / Revenue
19.1%
36.8%
Capex IntensityCapex / Revenue
0.0%
18.3%
Cash ConversionOCF / Net Profit
3.55×
TTM Free Cash FlowTrailing 4 quarters
$41.7M
$61.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
PGC
PGC
Q4 25
$14.4M
$43.1M
Q3 25
$9.7M
$36.2M
Q2 25
$14.1M
$15.9M
Q1 25
$3.6M
$-7.9M
Q4 24
$15.6M
$71.1M
Q3 24
$11.0M
$24.7M
Q2 24
$1.0M
$852.0K
Q1 24
$11.2M
$19.1M
Free Cash Flow
PBYI
PBYI
PGC
PGC
Q4 25
$14.4M
$28.8M
Q3 25
$9.7M
$34.0M
Q2 25
$14.1M
$9.9M
Q1 25
$3.6M
$-11.5M
Q4 24
$15.6M
$63.0M
Q3 24
$11.0M
$23.0M
Q2 24
$1.0M
$-431.0K
Q1 24
$18.0M
FCF Margin
PBYI
PBYI
PGC
PGC
Q4 25
19.1%
36.8%
Q3 25
17.7%
48.1%
Q2 25
26.8%
14.2%
Q1 25
7.7%
-17.8%
Q4 24
26.4%
101.9%
Q3 24
13.7%
40.6%
Q2 24
2.1%
-0.8%
Q1 24
33.9%
Capex Intensity
PBYI
PBYI
PGC
PGC
Q4 25
0.0%
18.3%
Q3 25
0.0%
3.1%
Q2 25
0.0%
8.6%
Q1 25
0.1%
5.6%
Q4 24
0.0%
13.1%
Q3 24
0.0%
3.0%
Q2 24
0.0%
2.3%
Q1 24
0.0%
2.1%
Cash Conversion
PBYI
PBYI
PGC
PGC
Q4 25
3.55×
Q3 25
1.10×
3.76×
Q2 25
2.41×
2.01×
Q1 25
1.21×
-1.04×
Q4 24
7.70×
Q3 24
0.54×
3.25×
Q2 24
0.11×
Q1 24
2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PBYI
PBYI

Segment breakdown not available.

PGC
PGC

Banking Segment$61.4M79%
Wealth Management Division$13.9M18%
Other$2.9M4%

Related Comparisons